On May 07, 2026, CVSA reported earnings of 1.98 USD per share (EPS) for Q3 26, beating the estimate of 1.75 USD, resulting in a 12.69% surprise. Revenue reached 487.03 million, compared to an expected 483.52 million, with a 0.73% difference. The market reacted with a +14.30% price change (close before vs. close after earnings).
Looking ahead to Q4 26, -- analysts forecast an EPS of 1.91 USD, with revenue projected to reach 496.36 million USD, implying an decrease of -3.54% EPS, and increase of 1.92% in Revenue from the last quarter.